Repeat stereotactic radiosurgery in the management of brain metastases from NSCLC: A case report and review of the literature

August 2013
Oncology Letters;2013, Vol. 6 Issue 4, p897
Academic Journal
Case Study
The aims of radiotherapeutic treatment of brain metastases include maintaining neurocognitive function and improvement of survival. Based on these premises, we present a case report in which the role of repeat stereotactic radiosurgery (SRS) was investigated in a patient with a recurrent brain metastasis from non-small cell lung cancer in the same area as previously treated with radiosurgery. A 40-year-old male caucasian patient was diagnosed with brain metastasis from non-small cell lung cancer (NSCLC) and underwent SRS. The patient developed a recurrence of the disease and a second SRS on the same area was performed. After 8 months, tumor restaging demonstrated a lesion compatible with a recurrence and the patient underwent surgery. Histological diagnosis following surgery revealed only the occurrence of radionecrosis. Radiotherapy was well-tolerated and no grade 3/4 neurological toxicity occurred. To date, no consensus exists on the efficacy of retreatment with SRS. Despite the limited number of studies in this field, in the present case report, we outline the outcomes of this unconventional approach.


Related Articles

  • Unyielding progress: recent advances in the treatment of central nervous system neoplasms with radiosurgery and radiation therapy. Ding, Dale; Yen, Chun-Po; Starke, Robert; Lee, Cheng-Chia; Sheehan, Jason // Journal of Neuro-Oncology;Sep2014, Vol. 119 Issue 3, p513 

    In the past decade, our understanding of the roles of external beam radiotherapy (EBRT) and stereotactic radiosurgery (SRS) in the management of brain tumors has dramatically improved. To highlight the changes and contemporary treatment approaches, we review the indications and outcomes of...

  • The RSSearch Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy. Davis, Joanne N.; Medbery III, Clinton; Sharma, Sanjeev; Danish, Adnan; Mahadevan, Anand // Radiation Oncology;2013, Vol. 8 Issue 1, p1 

    Background The RSSearchâ„¢ Registry is a multi-institutional, observational, ongoing registry established to standardize data collection from patients treated with stereotactic radiosurgery (SRS) and/or stereotactic body radiotherapy (SBRT). This report describes the design, patient...

  • Brain metastasis from melanoma: the prognostic value of varying sites of extracranial disease. Bates, James; Youn, Paul; Usuki, Kenneth; Walter, Kevin; Huggins, Christine; Okunieff, Paul; Milano, Michael // Journal of Neuro-Oncology;Nov2015, Vol. 125 Issue 2, p411 

    Patients with brain metastasis from melanoma have poor outcomes. Radiation is used both for prognostic and symptomatic value. We aimed to further clarify the role of stereotactic radiosurgery (SRS) and whole brain radiotherapy (WBRT) as well as the prognostic implication of various sites of...

  • Stereotactic radiosurgery and radiotherapy for meningiomas: biomarker predictors of patient outcome and response to therapy. Jensen, Randy L.; Minshew, Lindsey; Shrieve, Annabelle F.; Nan Hu; Shrieve, Dennis C. // Journal of Radiosurgery & SBRT;2012, Vol. 2 Issue 1, p41 

    Although surgery has traditionally been the primary treatment of meningiomas, stereotactic radiosurgery (SRS) and radiotherapy (SRT) techniques have become a standard part of the treatment approach to intracranial meningiomas. For incompletely resected or inoperable benign meningiomas, SRT and...

  • Functional outcome after stereotactic radiosugery to rolandic lesions. Kanner, A. A.; Bercu, M.; Matceyevsky, D.; Gez, E.; Shtrauss, N.; Corn, B. W. // Journal of Radiosurgery & SBRT;2013 Supplement 2.1, Vol. 2, p93 

    Introduction: Malignant and benign lesions that are located in eloquent brain tissue can cause considerable morbidity and may pose a significant treatment challenge. Brain metastases and meningiomas located in or near the central sulcus area are the most common relevant intra- and extra-axial...

  • Local control after fractionated stereotactic radiation therapy for brain metastases. Rajakesari, Selvan; Arvold, Nils; Jimenez, Rachel; Christianson, Laura; Horvath, Margaret; Claus, Elizabeth; Golby, Alexandra; Johnson, Mark; Dunn, Ian; Lee, Eudocia; Lin, Nancy; Friesen, Scott; Mannarino, Edward; Wagar, Matthew; Hacker, Fred; Weiss, Stephanie; Alexander, Brian // Journal of Neuro-Oncology;Nov2014, Vol. 120 Issue 2, p339 

    Stereotactic radiosurgery (SRS) is frequently used in the management of brain metastases, but concerns over potential toxicity limit applications for larger lesions or those in eloquent areas. Fractionated stereotactic radiation therapy (SRT) is often substituted for SRS in these cases. We...

  • Surgery for brain metastases. Yaeger, Kurt Andrew; Nair, M. Nathan // Surgical Neurology International;2013, Vol. 4 Issue Supp 4, pS203 

    The use of surgery in the treatment of brain metastases is controversial. Patients who present certain clinical characteristics may experience prolonged survival with resection compared with radiation therapy. Thus, for patients with a single metastatic lesion in the setting of well-controlled...

  • Intensity-modulated stereotactic radiosurgery for arteriovenous malformations: guidance for treatment planning. Sonier, Marcus; Gete, Ermias; Herbert, Chris; McKenzie, Michael; Murphy, James; Moiseenko, Vitali // Radiation Oncology;2014, Vol. 9 Issue 1, p1 

    Background: Stereotactic Radiosurgery (SRS) is a common tool used to treat Arteriovenous Malformations (AVMs) in anatomical locations associated with a risk of surgical complications. Despite high rates of clinical effectiveness, SRS carries a risk of toxicity as a result of radiation injury to...

  • Radiotherapy for lung cancer: Indications & outcome in patients > 75 years.  // Age & Ageing;Jan96 Supplement 1, Vol. 25, p45 

    Presents an abstract of the report `Radiotherapy for lung cancer: Indications & outcome in patients >= 75 years,' by C.J. Patterson et al, presented during the Autumn Meeting of the British Geriatrics Society on October 13 and 14, 1995 in London, England.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics